Ketrosden Triasmitra Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp955 (market cap 2.64T, 92.24M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 19× Hetzer Medical Indonesia Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (92.24M versus 51.66M). Which is the better fit depends on your goals.
| KETR | MEDS | |
|---|---|---|
Market Cap | 2.64T | 139.06B |
Volume | 92.24M | 51.66M |
Lot | 922.38K | 516.62K |
Turnover | 90.37B | 4.44B |
Average Price | 979.8 | 85.97 |
Value | 90.37B | 4.44B |
Indicative Equilibrium Price | 955 | 86 |
Indicative Equilibrium Volume | 29.3K | 9.62K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →